Research Article: Preeclampsia Patients in Owerri Metropolis: Studies of C-Reactive Protein and Uric Acid Status
Clinical Research and Clinical Reports · 2022
DOI: 10.31579/2835-8325/002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Research and Clinical Reports, 2022. Verfasst von Nnodim Johnkennedy.
Abstract (Originalsprache)
The goal of the study was to measure and assess the c-reactive protein and uric acid levels in preeclampsia patients. In the study, serum samples from 30 participants—15 preeclampsia patients and 15 healthy pregnant women—were tested for levels of c-reactive protein and uric acid. The level of c-reactive protein was determined using an enzymatic technique. The findings demonstrated that, at p0.05, the c-reactive protein concentration was substantially higher in preeclampsia patients (4.770.9 mg/dl) than in healthy pregnant women (1.30.39 mg/dl). Additionally, at p 0.05, preeclampsia patients had significantly higher uric acid concentrations (8.973.35 mg/dl) than healthy pregnant women (3.60.5 mg/dl). These results suggest that preeclampsia is associated with elevated levels of c-reactive protein and uric acid. Consequently, it likely act as a biochemical marker for preeclampsia.
Zitieren
APA
Johnkennedy, N. (2022). Research Article: Preeclampsia Patients in Owerri Metropolis: Studies of C-Reactive Protein and Uric Acid Status. Clinical Research and Clinical Reports. https://doi.org/10.31579/2835-8325/002
Vancouver
Johnkennedy N. Research Article: Preeclampsia Patients in Owerri Metropolis: Studies of C-Reactive Protein and Uric Acid Status. Clinical Research and Clinical Reports. 2022. doi:10.31579/2835-8325/002
BibTeX
@article{Johnkennedy2022,
author = {Johnkennedy, Nnodim},
title = {Research Article: Preeclampsia Patients in Owerri Metropolis: Studies of C-Reactive Protein and Uric Acid Status},
journal = {Clinical Research and Clinical Reports},
year = {2022},
doi = {10.31579/2835-8325/002}
}
EUVIMED